Boulder Ventures IV Annex LP

This profile gathers the share dealings of Boulder Ventures IV Annex LP in Oruka Therapeutics, Inc. We count 4 filings, every one of them for a trade on 6 April 2009.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 8 April 2009, reports a transaction in Oruka Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.